Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis
This study reports three cases of refractory anti-NMDAR encephalitis patients who exhibited persistent severe neuropsychiatric symptoms after first-line immunotherapy (glucocorticoids, intravenous Immunoglobulin) and long-term (maintenance) immunotherapy (mycophenolate mofetil). These patients recei...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2026-06-01
|
| Серія: | Frontiers in Immunology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1754979/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|